Senzar Asset Management as of Dec. 31, 2016
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 30 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sanofi-Aventis SA (SNY) | 13.2 | $50M | 1.2M | 40.43 | |
| Eli Lilly & Co. (LLY) | 10.7 | $40M | 547k | 73.51 | |
| Shire | 8.9 | $34M | 196k | 170.49 | |
| Allergan | 8.8 | $33M | 159k | 210.00 | |
| Anthem (ELV) | 8.2 | $31M | 216k | 143.78 | |
| Express Scripts Holding | 8.2 | $31M | 447k | 68.82 | |
| Tesaro | 5.1 | $19M | 142k | 134.33 | |
| Mallinckrodt Pub | 4.0 | $15M | 307k | 49.84 | |
| Halozyme Therapeutics (HALO) | 3.2 | $12M | 1.2M | 9.88 | |
| MiMedx (MDXG) | 2.9 | $11M | 1.2M | 8.85 | |
| Retrophin | 2.5 | $9.3M | 493k | 18.93 | |
| Healthways | 2.3 | $8.7M | 383k | 22.75 | |
| Centene Corporation (CNC) | 2.2 | $8.3M | 147k | 56.51 | |
| Myriad Genetics (MYGN) | 2.2 | $8.3M | 495k | 16.70 | |
| Momenta Pharmaceuticals | 2.1 | $8.0M | 532k | 15.05 | |
| Abbott Laboratories (ABT) | 2.0 | $7.5M | 196k | 38.41 | |
| Aerie Pharmaceuticals | 1.9 | $7.2M | 189k | 37.95 | |
| Corium Intl | 1.7 | $6.4M | 1.6M | 4.07 | |
| Foamix Pharmaceuticals | 1.6 | $6.1M | 551k | 11.10 | |
| Esperion Therapeutics (ESPR) | 1.2 | $4.6M | 364k | 12.50 | |
| Neuroderm Ltd F | 1.1 | $4.2M | 187k | 22.31 | |
| Concert Pharmaceuticals I equity | 1.1 | $4.1M | 401k | 10.24 | |
| Orthofix International Nv Com Stk | 1.1 | $4.0M | 111k | 36.18 | |
| Arena Pharmaceuticals | 0.7 | $2.7M | 1.9M | 1.43 | |
| Alder Biopharmaceuticals | 0.7 | $2.6M | 125k | 20.77 | |
| Inotek Pharmaceuticals | 0.7 | $2.5M | 412k | 6.09 | |
| Aviragen Therapeutics | 0.6 | $2.2M | 1.8M | 1.23 | |
| Paratek Pharmaceuticals | 0.5 | $1.9M | 125k | 15.38 | |
| Zogenix | 0.5 | $1.9M | 158k | 12.15 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.1 | $384k | 14k | 26.67 |
